|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 401 C St NE |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20002 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Minneapolis |
State | MN |
Zip Code | 55415 |
Country | USA |
|
5. Senate ID# 300856-12
|
||||||||
|
6. House ID# 377350000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Derek C. Brandt |
Date | 10/20/2020 6:25:41 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 348/H.R. 1763 Resident Physician Shortage Reduction Act of 2019; all provisions.
S. 2443: Investment in Tomorrow's Pediatric Health Care Workforce Act; all provisions.
S. 2546 / H.R. 2279: Safe Step Act; all provisions.
S. 3741/ H.R. 6644: The Health Care at Home Act; all provisions.
S. 3993: The Equal Access to Care Act; all provisions.
S. 4421/ H.R. 8283: the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act.
S. 7819/H.R. 4525 Eliminating the Provider Relief Fund Tax Penalties Act of 2020; all provisions.
H.R. 2781: Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act, section 4.
H.R. 748: Coronavirus Aid, Relief and Economic Security (CARES) Act; Title III.
H.R. 3502: Protecting People from Surprise Medical Bills Act; all provisions.
H.R. 6800: The Heroes Act; Title VI and Title X Division C.
H.R. 7059: The Coronavirus Provider Protection Act; all provisions.
H.R. 7255: Coronavirus Health Care Worker Wellness Act of 2020; all provisions.
Supporting policies to address the COVID-19 public health emergency, including funding for personal protective equipment, maintaining telemedicine coverage, ensuring access to affordable health coverage, and medical liability flexibility relating to COVID-19.
Funding for the CDC National Neurological Conditions Surveillance System.
Research into firearm morbidity and mortality prevention at CDC, fetal tissue research, AHRQ, and the NIH including the BRAIN Initiative.
Funding for Congressionally Directed Medical Research Programs at the DoD.
Lifting the federal ban restricting HHS from studying a Universal Patient Identifier.
Policy to address surprise medical billing.
Promoting interoperability in electronic health records.
Maintain work authorization for individuals currently in DACA status during the COVID-19 national emergency and other policies to support health care providers who live, work, and train in the United States but are not US citizens
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Derek |
Brandt |
|
|
|
Matthew |
Kerschner |
|
|
|
Michael |
Lisowski |
|
Senior Legislative Assistant, Rep. Joe Heck. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 3988: The Enhancing Preparedness Through Telehealth Act; all provisions.
H.R. 3107: Improving Seniors' Timely Access to Care Act of 2019; all provisions.
H.R. 4932/ S. 2741: CONNECT for Health Act; all provisions.
H.R. 7391, The Protect Telehealth Access Act; all provisions.
H.R. 7663: Protecting Access to Post-COVID-19 Telehealth Act; all provisions.
Supporting the implementation of CMSs final rule on Evaluation and Management (E/M) billing codes.
Supporting policies to address the COVID-19 pandemic, including expanding telemedicine, support for physician practices, and regulatory relief.
Supporting a permanent expansion of telehealth in Medicare, including eliminating on originating site and geographic restrictions.
Supporting policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, extending negotiated Rx discounts to be passed through to patients cost-sharing requirements, and capping beneficiary out-of-pocket costs in Medicare Part D.
Issues associated with Qualified Clinical Data Registry implementation, measures, and interoperability.
Improvements to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
Medicare coverage of oxygen therapy for cluster headaches.
Advocating for reform to stark and anti-kickback laws to promote value-based payment arrangements.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Derek |
Brandt |
|
|
|
Matthew |
Kerschner |
|
|
|
Michael |
Lisowski |
|
Senior Legislative Assistant, Rep. Joe Heck. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Strengthening the VA Centers of Excellence
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Derek |
Brandt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |